Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia - Hehlmann, Rüdiger; Lauseker, Michael; Jung-Munkwitz, Susanne; Leitner, Armin; Müller, Martin Christian; Pletsch, Nadine; Proetel, Ulrike; Haferlach, Claudia; Schlegelberger, Brigitte; Balleisen, Leopold; Hänel, Mathias; Pfirrmann, Markus; et al. (Journal of clinical oncology. [Englische Ausgabe], 2011)